company background image
NOVT logo

Novanta NasdaqGS:NOVT 주식 보고서

최종 가격

US$165.77

시가총액

US$6.0b

7D

-7.3%

1Y

15.9%

업데이트

18 Nov, 2024

데이터

회사 재무 +

Novanta Inc.

NasdaqGS:NOVT 주식 보고서

시가총액: US$6.0b

NOVT 주식 개요

는 자회사와 함께 미국 및 전 세계에서 정밀 의학 및 제조, 의료 솔루션, 로봇 공학 및 자동화 솔루션을 제공하고 있습니다. 자세한 내용

NOVT 기본 분석
눈송이 점수
가치 평가0/6
미래 성장3/6
과거 실적2/6
재무 상태3/6
배당금0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Novanta Inc. 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Novanta
과거 주가
현재 주가US$165.77
52주 최고치US$187.12
52주 최저치US$140.92
베타1.29
11개월 변경-7.15%
3개월 변경 사항-6.44%
1년 변경 사항15.94%
33년 변화-0.93%
5년 변화86.09%
IPO 이후 변화940.12%

최근 뉴스 및 업데이트

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Recent updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Nov 02
Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Oct 03
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Sep 19
With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Aug 23
Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Aug 03
Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Jul 11
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

주주 수익률

NOVTUS ElectronicUS 마켓
7D-7.3%-6.2%-2.1%
1Y15.9%28.0%29.6%

수익률 대 산업: NOVT 지난 1년 동안 28 %를 반환한 US Electronic 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: NOVT 지난 1년 동안 29.6 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is NOVT's price volatile compared to industry and market?
NOVT volatility
NOVT Average Weekly Movement4.9%
Electronic Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

안정적인 주가: NOVT 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: NOVT 의 주간 변동성( 5% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19682,900Matthijs Glastrawww.novanta.com

는 자회사와 함께 미국 및 전 세계에 정밀 의학 및 제조, 의료 솔루션, 로봇 공학 및 자동화 솔루션을 제공하고 있습니다. 이 회사는 세 가지 부문을 통해 운영됩니다: 정밀 의학 및 제조, 의료 솔루션, 로봇 공학 및 자동화입니다. 정밀 의학 및 제조 부문에서는 레이저 스캐닝, 빔 전달, CO2 레이저, 고체 레이저, 초고속 레이저, 광학 광 엔진 제품 등 포토닉스 기반 솔루션을 제공하여 산업 공정, 계측, 의료 및 생명 과학 이미징, DNA 시퀀싱, 의료 레이저 시술에 사용되는 포토닉스 기반 애플리케이션을 지원합니다.

Novanta Inc. 기본 사항 요약

Novanta 의 수익과 매출은 시가총액과 어떻게 비교하나요?
NOVT 기본 통계
시가총액US$6.04b
수익(TTM)US$60.13m
수익(TTM)US$922.75m

99.0x

P/E 비율

6.5x

P/S 비율

NOVT 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
NOVT 손익 계산서(TTM)
수익US$922.75m
수익 비용US$517.88m
총 이익US$404.88m
기타 비용US$344.74m
수익US$60.13m

최근 보고된 수익

Sep 27, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)1.67
총 마진43.88%
순이익 마진6.52%
부채/자본 비율61.6%

NOVT 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기